Testing a new glucose-ketone sensor for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a device that measures both glucose and ketone levels continuously. It may help people with type 1 diabetes better manage their condition by providing real-time data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least 1 year and your body makes little to no insulin.
- You currently use an insulin pump.
- You are able to follow the study procedures and give informed consent.
- You are willing to let the study team access your medical records.
- You can speak, read, and write in the language of the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests a wearable device that may measure insulin levels without needing blood draws. If you have type 1 diabetes, you might help researchers learn if this new sensor works for daily monitoring.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This study tests a new sensor that continuously measures ketone levels in people with type 1 diabetes who are also taking SGLT2 inhibitors. It aims to see if the sensor can help prevent diabetic ketoacidosis.
This study is testing a sensor to help prevent diabetic ketoacidosis (DKA), a serious complication of type 1 diabetes. If you join, you'll wear a sensor that checks your glucose and ketones.
This study tests a device that monitors ketone levels to help reduce the risk of diabetic ketoacidosis (DKA) for people with type 1 diabetes who are taking a class of medications called SGLT-2 inhibitors. The goal is to see if regular ketone tracking can make these medications safer.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.